These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 11921497)
1. Effects of the concomitant administration of tamsulosin (0.8 mg/day) on the pharmacokinetic and safety profile of theophylline (5 mg/kg): a placebo-controlled evaluation. Miyazawa Y; Starkey LP; Forrest A; Schentag JJ; Kamimura H; Swarz H; Ito Y J Int Med Res; 2002; 30(1):34-43. PubMed ID: 11921497 [TBL] [Abstract][Full Text] [Related]
2. Effects of the concomitant administration of tamsulosin (0.8 mg) on the pharmacokinetic and safety profile of intravenous digoxin (Lanoxin) in normal healthy subjects: a placebo-controlled evaluation. Miyazawa Y; Paul Starkey L; Forrest A; Schentag JJ; Kamimura H; Swarz H; Ito Y J Clin Pharm Ther; 2002 Feb; 27(1):13-9. PubMed ID: 11846858 [TBL] [Abstract][Full Text] [Related]
3. Concurrent administration of donepezil HCl and theophylline: assessment of pharmacokinetic changes following multiple-dose administration in healthy volunteers. Tiseo PJ; Foley K; Friedhoff LT Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):35-9. PubMed ID: 9839764 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of two doses (10 and 15 mg) of alfuzosin or tamsulosin (0.4 mg) once daily for treating symptomatic benign prostatic hyperplasia. Nordling J BJU Int; 2005 May; 95(7):1006-12. PubMed ID: 15839922 [TBL] [Abstract][Full Text] [Related]
6. Effect of indinavir on the single-dose pharmacokinetics of theophylline in healthy subjects. Mistry GC; Laurent A; Sterrett AT; Deutsch PJ J Clin Pharmacol; 1999 Jun; 39(6):636-42. PubMed ID: 10354968 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations. Franco-Salinas G; de la Rosette JJ; Michel MC Clin Pharmacokinet; 2010 Mar; 49(3):177-88. PubMed ID: 20170206 [TBL] [Abstract][Full Text] [Related]
8. [Omnic (tamsulosin) in the treatment of benign prostatic hyperplasia]. Lopatkin NA; Pytel' IuA; Trapeznikova MF; Loran OB; Mazo EB; Stepanov VN; Gres' AA; Savchenko NE; Vozianov AF; Babich VM Urologiia; 2001; (1):3-8. PubMed ID: 11233228 [No Abstract] [Full Text] [Related]
9. Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers. Peng WX; Li HD; Zhou HH Eur J Clin Pharmacol; 2003 Jul; 59(3):237-41. PubMed ID: 12756512 [TBL] [Abstract][Full Text] [Related]
10. Tegaserod coadministration does not alter the pharmacokinetics of theophylline in healthy subjects. Zhou H; Khalilieh S; Svendsen K; Pommier F; Osborne S; Appel-Dingemanse S; Lasseter K; McLeod JF J Clin Pharmacol; 2001 Sep; 41(9):987-93. PubMed ID: 11549104 [TBL] [Abstract][Full Text] [Related]
11. Enrofloxacin-theophylline interaction: influence of enrofloxacin on theophylline steady-state pharmacokinetics in the beagle dog. Intorre L; Mengozzi G; Maccheroni M; Bertini S; Soldani G J Vet Pharmacol Ther; 1995 Oct; 18(5):352-6. PubMed ID: 8587153 [TBL] [Abstract][Full Text] [Related]
12. The effect of udenafil on the hemodynamics of healthy male volunteers administered tamsulosin. Kim MG; Kim JR; Kim BH; Lim KS; Shin SG; Jang IJ; Yu KS; Cho JY Curr Med Res Opin; 2013 Jun; 29(6):685-93. PubMed ID: 23557068 [TBL] [Abstract][Full Text] [Related]
13. Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacin. Gisclon LG; Curtin CR; Fowler CL; Williams RR; Hafkin B; Natarajan J J Clin Pharmacol; 1997 Aug; 37(8):744-50. PubMed ID: 9378847 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of tamsulosin in subjects with normal and varying degrees of impaired renal function: an open-label single-dose and multiple-dose study. Wolzt M; Fabrizii V; Dorner GT; Zanaschka G; Leufkens P; Krauwinkel WJ; Eichler HG Eur J Clin Pharmacol; 1998 Jun; 54(4):367-73. PubMed ID: 9696967 [TBL] [Abstract][Full Text] [Related]
15. Phase I pilot study of the effects of trovafloxacin (CP-99,219) on the pharmacokinetics of theophylline in healthy men. Dickens GR; Wermeling D; Vincent J J Clin Pharmacol; 1997 Mar; 37(3):248-52. PubMed ID: 9089427 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Murraya koenigii- and Tribulus terrestris-based oral formulation versus tamsulosin in the treatment of benign prostatic hyperplasia in men aged >50 years: a double-blind, double-dummy, randomized controlled trial. Sengupta G; Hazra A; Kundu A; Ghosh A Clin Ther; 2011 Dec; 33(12):1943-52. PubMed ID: 22177370 [TBL] [Abstract][Full Text] [Related]
17. Effect of ranitidine on theophylline metabolism in healthy Koreans living in China. Kehoe WA; Sands CD; Long LF; Lan HH; Harralson AF; Shin HT; Jones DW Ann Pharmacother; 1996 Feb; 30(2):133-7. PubMed ID: 8835044 [TBL] [Abstract][Full Text] [Related]
18. Tamsulosin 0.4 mg once daily: tolerability in older and younger patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (symptomatic BPH). The European Tamsulosin Study Group. Chapple CR; Baert L; Thind P; Höfner K; Khoe GS; Spångberg A Eur Urol; 1997; 32(4):462-70. PubMed ID: 9412807 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia. Rahardjo D; Soebadi DM; Sugandi S; Birowo P; Djati W; Wahyudi I Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]